4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-008061
SVP, Head of Finance & Admin. sold 13,000 shares at $24.34 ($316,420)
- SVP, Head of Finance & Admin. acquired 13,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-01-26 | Option exercise 10b5-1 | +13,000 | $1.03 | $13,390 | 137,228 | D |
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-01-26 | Sale 10b5-1 | −13,000 | $24.34 | $316,420 | 124,228 | D |
| Derivatives | |||||||
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-01-26 | Option exercise · Stock option (right to buy) 10b5-1 | −13,000 | 12,740 | D | ||
| Open-market sales · 13,000 sh · avg $24.34 · $316,420 | |||||||
Loading xslF345X05/ownership.xml…